<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The prognostic significance of clonal karyotype status in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) is assessed after an extended follow-up period of 5 years </plain></SENT>
<SENT sid="1" pm="."><plain>There are three karyotype, single abnormalities or multiple abnormalities at the time of referral </plain></SENT>
<SENT sid="2" pm="."><plain>However, there is no correlation between the size of the abnormal clone and prognosis </plain></SENT>
<SENT sid="3" pm="."><plain>Karyotype status has independent prognostic significance in 'high risk' <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> so that patients with a refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>)/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t) and a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype survive significantly longer than those with an abnormal karyotype (P &lt; 0.001) and do not differ significantly from patients with refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> (RA) </plain></SENT>
<SENT sid="4" pm="."><plain>Significant differences in survival according to karyotype status are also seen in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_501'>myelomonocytic leukaemia</z:mpath> (P &lt; 0.001) but not in those with primary acquired sideroblastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> and RA </plain></SENT>
<SENT sid="5" pm="."><plain>Among patients studied sequentially, those who retained a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype survived significantly longer than those who developed an abnormality on follow-up (P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>The risk of leukaemic transformation was also increased in patients who presented with or subsequently developed a clonal karyotype abnormality compared with those who remained <z:mpath ids='MPATH_458'>normal</z:mpath> (P &lt; 0.05) </plain></SENT>
</text></document>